feed,title,long_url,short_url
Benzinga,The Rising Challenge for Intercept Pharmaceuticals: Analyst Downgrade Amid Ocaliva's DILI Concerns,https://benzinga.com/analyst-ratings/analyst-color/23/05/32537213/the-rising-challenge-for-intercept-pharmaceuticals-analyst-downgrade-amid-ocalivas-,https://da.gd/EwBvm
